Tolerance Bio Emerges from Steal with $17.2 Million to Advance Therapies for Immune Illnesses A leading biotechnology startup pioneering a novel approach for extending healthspan by manipulating the functions of the thymus, Tolerance Bio, has secured $17.2 million in an oversubscribed seed investment round to advance the pioneering concept of developing medications for rare diseases. Read more: https://nextdigitalhealth.com/funding-news/tolerance-bio-emerges-from-steal-with-17-2-million-to-advance-therapies-for-immune-illnesses/ #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #Biotechnology #HealthcareFunding